Immunotherapy of cancer beyond checkpoint inhibitors

FULL PROGRAM

DOWNLOAD PROGRAM

January 18th
January 19th

Registration

09:45 - 10:15h

Welcome

Richard Cornall
Jose Andrés Gómez Cantero
Joseba Campos Capelastegui
Ignacio Melero

10:15 - 10:30h

Session 1

Chairs: Juan José Lasarte/ Pedro Berraondo

Opening Lecture: “Dendritic Cell Reprogramming for Cancer Immunotherapy”

Filipe Pereira- Lund University in Sweden

10:30 - 10:50h

Q&A

10:50 - 11:00h

“Cross-priming and costimulation cancer immunotherapy”

Ignacio Melero – CIMA / CUN / University of Oxfor

11:00 - 11:20h

Q&A

11:20 - 11:30h

“cDC-1 dendritic cells in cancer immunotherapy”

David Sancho – CNIC, Spain

11:30 - 11:50h

Q&A

11:50 - 12:00h

Break

12:00-12:30h

Session 2

Chairs: Alvaro Teijeira / Fernando Aranda

“Neutrophil extracellular traps (NETs) in cancer”

Mikala Egeblad – Johns Hopkins University School of Medicine, USA

12:30 - 12:50h

Q&A

12:50 - 13:00h

“The dual role of inflammation in cancer immunity”

Santiago Zelenay – Cancer Research UK Manchester Institute, UK

13:00 - 13:20h

Q&A

13:20 - 13:30h

“GDF- 15 as an actionable mediator in cachexia and immunosuppression”

Jörg Wischhusen – University of Würzburg School of Medicine, Germany

13:30 - 13:50h

Q&A

13:50 - 14:00h

“Macrophage functions and targets in the tumour microenvironment of high-grade serous ovarian cancer”

Frances Balkwill – Barts Cancer Institute, Queen Mary University of London, UK

14:00 - 14:20h

Q&A

14:20 - 14:30h

LUNCH-Buffet

14:30 - 15:30h

Session 3

Chairs: Miguel F. Sanmamed / María Rodríguez Ruiz

“Rational combination immunotherapies: mechanistic insights and emerging strategies”

Alfred Zippelius – University of Basel, Switzerland

15:30 - 15:50h

Q&A

15:50 - 16:00h

“Vaccination against immunosuppressive factors”

Inge Marie Svane – Center for Cancer Immune Therapy (CCIT). Denmark

16:00 - 16:20h

Q&A

16:20 - 16:30h

“Window of opportunity trials in cancer immunotherapy”

Marleen Kok – Netherlands Cancer Institute, Holland

16:30 - 16:50h

Q&A

16:50 - 17:00h

Break

17:00 - 17:30h

Session 4

Chairs: Ignacio Melero / David Withers

“Chromosomal chaos and immune surveillance”

Eileen Parkes – University of Oxford, UK

17:30 - 17:50h

Q&A

17:50 - 18:00h

“Understanding determinants of response, resistance and side effects in cancer treatment with checkpoint inhibitors”

Benjamin Fairfax – University of Oxford, UK

18:00 - 18:20h

Q&A

18:20 - 18:30h

“Digital spatial profiling to explore immune cell infiltrates”

Fadi Issa – Nuffield Department of Surgical Sciences, University of Oxford, UK

18:30 - 18:50h

Q&A

18:50 - 19:00h

Barcelona CaixaResearch Institute’s Presentation

Chairs: Gabriel Rabinovich / Angel Font

09:00 - 9:15h

Session 5

Chairs: Gabriel Rabinovich / Francisco Sanchez Madrid

“The discovery and development of checkpoint inhibitors”

Jim Allison – M. D. Anderson Cancer Center, University of Texas, USA

09:15 - 09:35h

Q&A

09:35 - 09:45h

“Glycocheckpoints”

Gabriel Rabinovich – CaixaResearch Institute, Spain

09:45 - 10:05h

Q&A

10:05 - 10:15h

“The tumor microenvironment in response to immunotherapy”

Padmanee Sharma – M. D. Anderson Cancer Center, University of Texas, USA

10:15 - 10:35h

Q&A

10:35 - 10:45h

Break

10:45 - 11:15h

Session 6

Chairs: Antonio González / José Luis Pérez Gracia

“Novel immunotherapy combinations for the treatment of melanoma”

Paolo Ascierto – Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Italy

11:15 - 11:35h

Q&A

11:35 - 11:45h

“Intratumoral agents for cancer immunotherapy”

Aurélien Marabelle – Université Paris-Saclay, France

11.45 - 12:05h

Q&A

12:05 - 12:15h

“Liver cancer at a turning point: the (r)evolution of immunotherapy”

Bruno Sangro – Clínica Universidad de Navarra, Spain

12:15 - 12:35h

Q&A

12:35 - 12:45h

“Novel anti PD1+CTLA-4 combinations to treat digestive tumors”

Anthony B. El-Khoueiry – USC Norris Comprehensive Cancer Center, USA

12:45 - 13:05h

Q&A

13:05 - 13:15h

LUNCH-Buffet

13:15 - 14:15h

“Estimating and understanding cancer heterogeneity”

Nicholas McGranahan – UCL Cancer Institute, UK

14:15 - 14:35h

Q&A

14:35 - 14:45h

Closing Keynote Lecture: “Deciphering and targeting tumor-immune cell interactions in cancer”

Kurt Schalper – Yale School of Medicine, USA

14:45 - 15:05h

Q&A

15:05 - 15:15h

Meeting Adjourns

Ignacio Melero

15:15 - 15:20h

Cutting Edge Cancer Immunotherapies on Course to Cures

CaixaForum Madrid, 18th and 19th of January 2027

REGISTRATION CLOSED

EVENT WILL START IN

FULL PROGRAM

DOWNLOAD PROGRAM

Registration

Welcome

Richard Cornall Jose Andrés Gómez Cantero Joseba Campos Capelastegui Ignacio Melero

Session 1

Chairs: Juan José Lasarte/ Pedro Berraondo

Opening Lecture: “Dendritic Cell Reprogramming for Cancer Immunotherapy”

Filipe Pereira- Lund University in Sweden

Q&A

“Cross-priming and costimulation cancer immunotherapy”

Ignacio Melero – CIMA / CUN / University of Oxfor

Q&A

“cDC-1 dendritic cells in cancer immunotherapy”

David Sancho – CNIC, Spain

Q&A

Break

Session 2

Chairs: Alvaro Teijeira / Fernando Aranda

“Neutrophil extracellular traps (NETs) in cancer”

Mikala Egeblad – Johns Hopkins University School of Medicine, USA

Q&A

“The dual role of inflammation in cancer immunity”

Santiago Zelenay – Cancer Research UK Manchester Institute, UK

Q&A

“GDF- 15 as an actionable mediator in cachexia and immunosuppression”

Jörg Wischhusen – University of Würzburg School of Medicine, Germany

Q&A

“Macrophage functions and targets in the tumour microenvironment of high-grade serous ovarian cancer”

Frances Balkwill – Barts Cancer Institute, Queen Mary University of London, UK

Q&A

LUNCH-Buffet

Session 3

Chairs: Miguel F. Sanmamed / María Rodríguez Ruiz

“Rational combination immunotherapies: mechanistic insights and emerging strategies”

Alfred Zippelius – University of Basel, Switzerland

Q&A

“Vaccination against immunosuppressive factors”

Inge Marie Svane – Center for Cancer Immune Therapy (CCIT). Denmark

Q&A

“Window of opportunity trials in cancer immunotherapy”

Marleen Kok – Netherlands Cancer Institute, Holland

Q&A

Break

Session 4

Chairs: Ignacio Melero / David Withers

“Chromosomal chaos and immune surveillance”

Eileen Parkes – University of Oxford, UK

Q&A

“Understanding determinants of response, resistance and side effects in cancer treatment with checkpoint inhibitors”

Benjamin Fairfax – University of Oxford, UK

Q&A

“Digital spatial profiling to explore immune cell infiltrates”

Fadi Issa – Nuffield Department of Surgical Sciences, University of Oxford, UK

Q&A

Barcelona CaixaResearch Institute’s Presentation

Chairs: Gabriel Rabinovich / Angel Font

Session 5

Chairs: Gabriel Rabinovich / Francisco Sanchez Madrid

“The discovery and development of checkpoint inhibitors”

Jim Allison – M. D. Anderson Cancer Center, University of Texas, USA

Q&A

“Glycocheckpoints”

Gabriel Rabinovich – CaixaResearch Institute, Spain

Q&A

“The tumor microenvironment in response to immunotherapy”

Padmanee Sharma – M. D. Anderson Cancer Center, University of Texas, USA

Q&A

Break

Session 6

Chairs: Antonio González / José Luis Pérez Gracia

“Novel immunotherapy combinations for the treatment of melanoma”

Paolo Ascierto – Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Italy

Q&A

“Intratumoral agents for cancer immunotherapy”

Aurélien Marabelle – Université Paris-Saclay, France

CaixaForum Madrid, 18^th and 19^th of January 2027

Richard Cornall
Jose Andrés Gómez Cantero
Joseba Campos Capelastegui
Ignacio Melero